APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-infective Drugs for Animals

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Anti-infective Drugs for Animals Market Outlook and Growth Opportunities 2026

31 December 2025192 pages

Choose your research edition.

Industry ResearchAnti-infective Drugs for Animals Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-infective Drugs for Animals Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Anti-infective Drugs for Animals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-infective Drugs for Animals Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-infective Drugs for Animals Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Anti-infective Drugs for Animals market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Anti-infective Drugs for Animals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anti-infective Drugs for Animals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-infective Drugs for Animals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Anti-infective Drugs for Animals market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Anti-infective Drugs for Animals market include AG Supply, Vetoquinol SA, Bayer, Boehringer Ingelheim, Phibro Animal Health Corporation, Elanco, Merck, Ceva Santé Animale and Zoetis Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Anti-infective Drugs for Animals market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anti-infective Drugs for Animals and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anti-infective Drugs for Animals sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anti-infective Drugs for Animals market size, projected growth trends, production technologies, key applications, and end-use industries.

Anti-infective Drugs for Animals Segment by Company

AG Supply

Vetoquinol SA

Bayer

Boehringer Ingelheim

Phibro Animal Health Corporation

Elanco

Merck

Ceva Santé Animale

Zoetis Inc.

Anti-infective Drugs for Animals Segment by Type

Antifungals

Antibacterial

Antivirals

Others

Anti-infective Drugs for Animals Segment by Application

Cattle

Cats

Dogs

Other Animals

Anti-infective Drugs for Animals Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Anti-infective Drugs for Animals status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Anti-infective Drugs for Animals market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Anti-infective Drugs for Animals significant trends, drivers, influence factors in global and regions.

6. To analyze Anti-infective Drugs for Animals competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-infective Drugs for Animals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-infective Drugs for Animals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-infective Drugs for Animals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Anti-infective Drugs for Animals market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Anti-infective Drugs for Animals industry.

Chapter 3: Detailed analysis of Anti-infective Drugs for Animals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Anti-infective Drugs for Animals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Anti-infective Drugs for Animals in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Anti-infective Drugs for Animals Industry Trends Table 2. Anti-infective Drugs for Animals Industry Drivers Table 3. Anti-infective Drugs for Animals Industry Opportunities and Challenges Table 4. Anti-infective Drugs for Animals Industry Restraints Table 5. Global Anti-infective Drugs for Animals Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Anti-infective Drugs for Animals Revenue Share by Company (2021-2026) Table 7. Global Anti-infective Drugs for Animals Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Anti-infective Drugs for Animals Sales Volume Share by Company (2021-2026) Table 9. Global Anti-infective Drugs for Animals Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Anti-infective Drugs for Animals Company Ranking, (2024-2026) & (USD Million) Table 11. Global Anti-infective Drugs for Animals Key Company Manufacturing Base & Headquarters Table 12. Global Anti-infective Drugs for Animals Company, Product Type & Application Table 13. Global Anti-infective Drugs for Animals Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Anti-infective Drugs for Animals by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Antifungals Table 18. Significant Companies of Antibacterial Table 19. Significant Companies of Antivirals Table 20. Significant Companies of Others Table 21. Global Anti-infective Drugs for Animals Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Anti-infective Drugs for Animals Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Anti-infective Drugs for Animals Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Anti-infective Drugs for Animals Sales Volume Share by Type (2021-2026) Table 25. Global Anti-infective Drugs for Animals Sales Volume Share by Type (2027-2032) Table 26. Global Anti-infective Drugs for Animals Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Anti-infective Drugs for Animals Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Anti-infective Drugs for Animals Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Anti-infective Drugs for Animals Sales Value Share by Type (2021-2026) Table 30. Global Anti-infective Drugs for Animals Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Cattle Table 32. Significant Companies of Cats Table 33. Significant Companies of Dogs Table 34. Significant Companies of Other Animals Table 35. Global Anti-infective Drugs for Animals Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Anti-infective Drugs for Animals Sales Volume by Application (2021-2026) & (K Units) Table 37. Global Anti-infective Drugs for Animals Sales Volume by Application (2027-2032) & (K Units) Table 38. Global Anti-infective Drugs for Animals Sales Volume Share by Application (2021-2026) Table 39. Global Anti-infective Drugs for Animals Sales Volume Share by Application (2027-2032) Table 40. Global Anti-infective Drugs for Animals Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Anti-infective Drugs for Animals Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Anti-infective Drugs for Animals Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Anti-infective Drugs for Animals Sales Value Share by Application (2021-2026) Table 44. Global Anti-infective Drugs for Animals Sales Value Share by Application (2027-2032) Table 45. Global Anti-infective Drugs for Animals Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Anti-infective Drugs for Animals Sales by Region (2021-2026) & (K Units) Table 47. Global Anti-infective Drugs for Animals Sales Market Share by Region (2021-2026) Table 48. Global Anti-infective Drugs for Animals Sales by Region (2027-2032) & (K Units) Table 49. Global Anti-infective Drugs for Animals Sales Market Share by Region (2027-2032) Table 50. Global Anti-infective Drugs for Animals Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Anti-infective Drugs for Animals Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Anti-infective Drugs for Animals Sales Value Share by Region (2021-2026) Table 53. Global Anti-infective Drugs for Animals Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Anti-infective Drugs for Animals Sales Value Share by Region (2027-2032) Table 55. Global Anti-infective Drugs for Animals Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Anti-infective Drugs for Animals Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Anti-infective Drugs for Animals Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global Anti-infective Drugs for Animals Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Anti-infective Drugs for Animals Sales by Country (2021-2026) & (K Units) Table 60. Global Anti-infective Drugs for Animals Sales Market Share by Country (2021-2026) Table 61. Global Anti-infective Drugs for Animals Sales by Country (2027-2032) & (K Units) Table 62. Global Anti-infective Drugs for Animals Sales Market Share by Country (2027-2032) Table 63. Global Anti-infective Drugs for Animals Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Anti-infective Drugs for Animals Sales Value Market Share by Country (2021-2026) Table 65. Global Anti-infective Drugs for Animals Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Anti-infective Drugs for Animals Sales Value Market Share by Country (2027-2032) Table 67. AG Supply Company Information Table 68. AG Supply Business Overview Table 69. AG Supply Anti-infective Drugs for Animals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. AG Supply Anti-infective Drugs for Animals Product Portfolio Table 71. AG Supply Recent Development Table 72. Vetoquinol SA Company Information Table 73. Vetoquinol SA Business Overview Table 74. Vetoquinol SA Anti-infective Drugs for Animals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Vetoquinol SA Anti-infective Drugs for Animals Product Portfolio Table 76. Vetoquinol SA Recent Development Table 77. Bayer Company Information Table 78. Bayer Business Overview Table 79. Bayer Anti-infective Drugs for Animals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Bayer Anti-infective Drugs for Animals Product Portfolio Table 81. Bayer Recent Development Table 82. Boehringer Ingelheim Company Information Table 83. Boehringer Ingelheim Business Overview Table 84. Boehringer Ingelheim Anti-infective Drugs for Animals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Boehringer Ingelheim Anti-infective Drugs for Animals Product Portfolio Table 86. Boehringer Ingelheim Recent Development Table 87. Phibro Animal Health Corporation Company Information Table 88. Phibro Animal Health Corporation Business Overview Table 89. Phibro Animal Health Corporation Anti-infective Drugs for Animals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Phibro Animal Health Corporation Anti-infective Drugs for Animals Product Portfolio Table 91. Phibro Animal Health Corporation Recent Development Table 92. Elanco Company Information Table 93. Elanco Business Overview Table 94. Elanco Anti-infective Drugs for Animals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Elanco Anti-infective Drugs for Animals Product Portfolio Table 96. Elanco Recent Development Table 97. Merck Company Information Table 98. Merck Business Overview Table 99. Merck Anti-infective Drugs for Animals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Merck Anti-infective Drugs for Animals Product Portfolio Table 101. Merck Recent Development Table 102. Ceva Santé Animale Company Information Table 103. Ceva Santé Animale Business Overview Table 104. Ceva Santé Animale Anti-infective Drugs for Animals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Ceva Santé Animale Anti-infective Drugs for Animals Product Portfolio Table 106. Ceva Santé Animale Recent Development Table 107. Zoetis Inc. Company Information Table 108. Zoetis Inc. Business Overview Table 109. Zoetis Inc. Anti-infective Drugs for Animals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Zoetis Inc. Anti-infective Drugs for Animals Product Portfolio Table 111. Zoetis Inc. Recent Development Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. Anti-infective Drugs for Animals Distributors List Table 115. Anti-infective Drugs for Animals Customers List Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Anti-infective Drugs for Animals Product Image Figure 2. Global Anti-infective Drugs for Animals Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-infective Drugs for Animals Sales Value (2021-2032) & (US$ Million) Figure 4. Global Anti-infective Drugs for Animals Sales (2021-2032) & (K Units) Figure 5. Global Anti-infective Drugs for Animals Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Anti-infective Drugs for Animals Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Antifungals Image Figure 10. Antibacterial Image Figure 11. Antivirals Image Figure 12. Others Image Figure 13. Global Anti-infective Drugs for Animals Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Anti-infective Drugs for Animals Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Anti-infective Drugs for Animals Sales Volume Share by Type (2021-2032) Figure 16. Global Anti-infective Drugs for Animals Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Anti-infective Drugs for Animals Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Anti-infective Drugs for Animals Sales Value Share by Type (2021-2032) Figure 19. Cattle Image Figure 20. Cats Image Figure 21. Dogs Image Figure 22. Other Animals Image Figure 23. Global Anti-infective Drugs for Animals Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Anti-infective Drugs for Animals Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Anti-infective Drugs for Animals Sales Volume Share by Application (2021-2032) Figure 26. Global Anti-infective Drugs for Animals Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Anti-infective Drugs for Animals Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Anti-infective Drugs for Animals Sales Value Share by Application (2021-2032) Figure 29. Global Anti-infective Drugs for Animals Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global Anti-infective Drugs for Animals Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Anti-infective Drugs for Animals Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Anti-infective Drugs for Animals Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Anti-infective Drugs for Animals Sales Value (2021-2032) & (US$ Million) Figure 34. North America Anti-infective Drugs for Animals Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Anti-infective Drugs for Animals Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Anti-infective Drugs for Animals Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Anti-infective Drugs for Animals Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Anti-infective Drugs for Animals Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Anti-infective Drugs for Animals Sales Value (2021-2032) & (US$ Million) Figure 40. South America Anti-infective Drugs for Animals Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Anti-infective Drugs for Animals Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Anti-infective Drugs for Animals Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Anti-infective Drugs for Animals Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Anti-infective Drugs for Animals Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Antifungals
  • Antibacterial
  • Antivirals
  • Others
Applications
  • Cattle
  • Cats
  • Dogs
  • Other Animals
Companies covered
  • AG Supply
  • Vetoquinol SA
  • Bayer
  • Boehringer Ingelheim
  • Phibro Animal Health Corporation
  • Elanco
  • Merck
  • Ceva Santé Animale
  • Zoetis Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anti-infective Drugs for Animals Sales Value (2021-2032)
  4. 1.2.2 Global Anti-infective Drugs for Animals Sales Volume (2021-2032)
  5. 1.2.3 Global Anti-infective Drugs for Animals Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Anti-infective Drugs for Animals Market Dynamics
  1. 2.1 Anti-infective Drugs for Animals Industry Trends
  2. 2.2 Anti-infective Drugs for Animals Industry Drivers
  3. 2.3 Anti-infective Drugs for Animals Industry Opportunities and Challenges
  4. 2.4 Anti-infective Drugs for Animals Industry Restraints
3 Anti-infective Drugs for Animals Market by Company
  1. 3.1 Global Anti-infective Drugs for Animals Company Revenue Ranking in 2025
  2. 3.2 Global Anti-infective Drugs for Animals Revenue by Company (2021-2026)
  3. 3.3 Global Anti-infective Drugs for Animals Sales Volume by Company (2021-2026)
  4. 3.4 Global Anti-infective Drugs for Animals Average Price by Company (2021-2026)
  5. 3.5 Global Anti-infective Drugs for Animals Company Ranking (2024-2026)
  6. 3.6 Global Anti-infective Drugs for Animals Company Manufacturing Base and Headquarters
  7. 3.7 Global Anti-infective Drugs for Animals Company Product Type and Application
  8. 3.8 Global Anti-infective Drugs for Animals Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Anti-infective Drugs for Animals Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Anti-infective Drugs for Animals Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Anti-infective Drugs for Animals Market by Type
  1. 4.1 Anti-infective Drugs for Animals Type Introduction
  2. 4.1.1 Antifungals
  3. 4.1.2 Antibacterial
  4. 4.1.3 Antivirals
  5. 4.1.4 Others
  6. 4.2 Global Anti-infective Drugs for Animals Sales Volume by Type
  7. 4.2.1 Global Anti-infective Drugs for Animals Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Anti-infective Drugs for Animals Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Anti-infective Drugs for Animals Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Anti-infective Drugs for Animals Sales Value by Type
  11. 4.3.1 Global Anti-infective Drugs for Animals Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Anti-infective Drugs for Animals Sales Value by Type (2021-2032)
  13. 4.3.3 Global Anti-infective Drugs for Animals Sales Value Share by Type (2021-2032)
5 Anti-infective Drugs for Animals Market by Application
  1. 5.1 Anti-infective Drugs for Animals Application Introduction
  2. 5.1.1 Cattle
  3. 5.1.2 Cats
  4. 5.1.3 Dogs
  5. 5.1.4 Other Animals
  6. 5.2 Global Anti-infective Drugs for Animals Sales Volume by Application
  7. 5.2.1 Global Anti-infective Drugs for Animals Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Anti-infective Drugs for Animals Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Anti-infective Drugs for Animals Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Anti-infective Drugs for Animals Sales Value by Application
  11. 5.3.1 Global Anti-infective Drugs for Animals Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Anti-infective Drugs for Animals Sales Value by Application (2021-2032)
  13. 5.3.3 Global Anti-infective Drugs for Animals Sales Value Share by Application (2021-2032)
6 Anti-infective Drugs for Animals Regional Sales and Value Analysis
  1. 6.1 Global Anti-infective Drugs for Animals Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Anti-infective Drugs for Animals Sales by Region (2021-2032)
  3. 6.2.1 Global Anti-infective Drugs for Animals Sales by Region: 2021-2026
  4. 6.2.2 Global Anti-infective Drugs for Animals Sales by Region (2027-2032)
  5. 6.3 Global Anti-infective Drugs for Animals Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Anti-infective Drugs for Animals Sales Value by Region (2021-2032)
  7. 6.4.1 Global Anti-infective Drugs for Animals Sales Value by Region: 2021-2026
  8. 6.4.2 Global Anti-infective Drugs for Animals Sales Value by Region (2027-2032)
  9. 6.5 Global Anti-infective Drugs for Animals Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Anti-infective Drugs for Animals Sales Value (2021-2032)
  12. 6.6.2 North America Anti-infective Drugs for Animals Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Anti-infective Drugs for Animals Sales Value (2021-2032)
  15. 6.7.2 Europe Anti-infective Drugs for Animals Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Anti-infective Drugs for Animals Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Anti-infective Drugs for Animals Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Anti-infective Drugs for Animals Sales Value (2021-2032)
  21. 6.9.2 South America Anti-infective Drugs for Animals Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Anti-infective Drugs for Animals Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Anti-infective Drugs for Animals Sales Value Share by Country, 2025 VS 2032
7 Anti-infective Drugs for Animals Country-level Sales and Value Analysis
  1. 7.1 Global Anti-infective Drugs for Animals Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Anti-infective Drugs for Animals Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Anti-infective Drugs for Animals Sales by Country (2021-2032)
  4. 7.3.1 Global Anti-infective Drugs for Animals Sales by Country (2021-2026)
  5. 7.3.2 Global Anti-infective Drugs for Animals Sales by Country (2027-2032)
  6. 7.4 Global Anti-infective Drugs for Animals Sales Value by Country (2021-2032)
  7. 7.4.1 Global Anti-infective Drugs for Animals Sales Value by Country (2021-2026)
  8. 7.4.2 Global Anti-infective Drugs for Animals Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Anti-infective Drugs for Animals Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Anti-infective Drugs for Animals Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Anti-infective Drugs for Animals Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AG Supply
  2. 8.1.1 AG Supply Company Information
  3. 8.1.2 AG Supply Business Overview
  4. 8.1.3 AG Supply Anti-infective Drugs for Animals Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 AG Supply Anti-infective Drugs for Animals Product Portfolio
  6. 8.1.5 AG Supply Recent Developments
  7. 8.2 Vetoquinol SA
  8. 8.2.1 Vetoquinol SA Company Information
  9. 8.2.2 Vetoquinol SA Business Overview
  10. 8.2.3 Vetoquinol SA Anti-infective Drugs for Animals Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Vetoquinol SA Anti-infective Drugs for Animals Product Portfolio
  12. 8.2.5 Vetoquinol SA Recent Developments
  13. 8.3 Bayer
  14. 8.3.1 Bayer Company Information
  15. 8.3.2 Bayer Business Overview
  16. 8.3.3 Bayer Anti-infective Drugs for Animals Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Bayer Anti-infective Drugs for Animals Product Portfolio
  18. 8.3.5 Bayer Recent Developments
  19. 8.4 Boehringer Ingelheim
  20. 8.4.1 Boehringer Ingelheim Company Information
  21. 8.4.2 Boehringer Ingelheim Business Overview
  22. 8.4.3 Boehringer Ingelheim Anti-infective Drugs for Animals Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Boehringer Ingelheim Anti-infective Drugs for Animals Product Portfolio
  24. 8.4.5 Boehringer Ingelheim Recent Developments
  25. 8.5 Phibro Animal Health Corporation
  26. 8.5.1 Phibro Animal Health Corporation Company Information
  27. 8.5.2 Phibro Animal Health Corporation Business Overview
  28. 8.5.3 Phibro Animal Health Corporation Anti-infective Drugs for Animals Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Phibro Animal Health Corporation Anti-infective Drugs for Animals Product Portfolio
  30. 8.5.5 Phibro Animal Health Corporation Recent Developments
  31. 8.6 Elanco
  32. 8.6.1 Elanco Company Information
  33. 8.6.2 Elanco Business Overview
  34. 8.6.3 Elanco Anti-infective Drugs for Animals Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Elanco Anti-infective Drugs for Animals Product Portfolio
  36. 8.6.5 Elanco Recent Developments
  37. 8.7 Merck
  38. 8.7.1 Merck Company Information
  39. 8.7.2 Merck Business Overview
  40. 8.7.3 Merck Anti-infective Drugs for Animals Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Merck Anti-infective Drugs for Animals Product Portfolio
  42. 8.7.5 Merck Recent Developments
  43. 8.8 Ceva Santé Animale
  44. 8.8.1 Ceva Santé Animale Company Information
  45. 8.8.2 Ceva Santé Animale Business Overview
  46. 8.8.3 Ceva Santé Animale Anti-infective Drugs for Animals Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Ceva Santé Animale Anti-infective Drugs for Animals Product Portfolio
  48. 8.8.5 Ceva Santé Animale Recent Developments
  49. 8.9 Zoetis Inc.
  50. 8.9.1 Zoetis Inc. Company Information
  51. 8.9.2 Zoetis Inc. Business Overview
  52. 8.9.3 Zoetis Inc. Anti-infective Drugs for Animals Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Zoetis Inc. Anti-infective Drugs for Animals Product Portfolio
  54. 8.9.5 Zoetis Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Anti-infective Drugs for Animals Value Chain Analysis
  2. 9.1.1 Anti-infective Drugs for Animals Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Anti-infective Drugs for Animals Sales Mode & Process
  6. 9.2 Anti-infective Drugs for Animals Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Anti-infective Drugs for Animals Distributors
  9. 9.2.3 Anti-infective Drugs for Animals Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst